Sutro Biopharma reported $62 million in 2024 revenue, down from $153.7 million in 2023, and announced a pipeline restructuring.

SCHA is another great small-cap ETF if you want a broadly diversified fund with a low-cost structure. The fund has assets ...

The program allows patients with serious or immediately life ... and this is why these shares take the top spot in our list ...

Shares priced under $5, commonly referred to as penny stocks, are a tempting bet for investors chasing big returns with ...

A proposed US$150 million share repurchase program reflects confidence in future prospects, pending Israeli court approval. Click to explore a detailed breakdown of our findings in Nano Dimension ...

Penny stocks can be highly tempting due to their potential for exponential growth. However, it’s critical to carefully assess their pros and cons. When investing, your capital is at risk.

We recently published a list of 12 Penny Stocks with Insider Buying in 2025. In this article, we are going to take a look at where CAMP4 Therapeutics Corporation (NASDAQ:CAMP) stands against other ...

Penny stocks are low-priced securities that trade for less than $5 a share. Wondering where to buy them? It's a good question: Not all brokers offer them, and those that do may charge higher fees.

Penny stock below ₹50: Shree Rama Newsprint share price was locked at 5% lower circuit at ₹34.57 apiece on BSE Tuesday, snapping its six session rally. The trading volumes for Shree Rama ...

Looking for top momentum shares to buy? While not without risk, these penny stocks are worth serious consideration, in my opinion. When investing, your capital is at risk. The value of your ...

President Trump wants to ditch the penny, a move that some experts say is long overdue. Advocates of the least-valuable coin say it should stick around. WSJ examines the question of whether or not ...

Next: Get access to a new market-moving chart every day featuring a stock flashing clear technical signals. See today's pick now. The company’s decision to withdraw the submission was based on ...